Search Results - Lisette Volpe‐Gillot
- Showing 1 - 2 results of 2
-
1
Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers by Olivier Hanon, Jean‐Sébastien Vidal, Sylvain Lehmann, Stéphanie Bombois, Bernadette Allinquant, Jean‐Marc Tréluyer, Patrick Gelé, Christine Delmaire, Frédéric Blanc, Jean‐François Mangin, Luc Buée, Jacques Touchon, Jacques Hugon, Bruno Vellas, Evelyne Galbrun, Athanase Bénétos, Gilles Berrut, Éléna Paillaud, David Wallon, Giovanni Castelnovo, Lisette Volpe‐Gillot, Marc Paccalin, P.H. Robert, Olivier Godefroy, Thierry Dantoine, Vincent Camus, Joël Belmin, Pierre Vandel, Jean‐Luc Novella, Emmanuelle Duron, Anne‐Sophie Rigaud, Susanna Schraen‐Maschke, Audrey Gabelle
Published 2018Artigo -
2
Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study by Olivier Hanon, Jean‐Sébastien Vidal, Sylvain Lehmann, Stéphanie Bombois, Bernadette Allinquant, Christiane Baret‐Rose, Jean‐Marc Tréluyer, Hendy Abdoul, Patrick Gelé, Christine Delmaire, Fréderic Blanc, Jean‐François Mangin, Luc Buée, Jacques Touchon, Jacques Hugon, Bruno Vellas, Evelyne Galbrun, Athanase Bénétos, Gilles Berrut, Éléna Paillaud, David Wallon, Giovanni Castelnovo, Lisette Volpe‐Gillot, Marc Paccalin, Philippe Robert, Olivier Godefroy, Vincent Camus, Joël Belmin, Pierre Vandel, Jean‐Luc Novella, Emmanuelle Duron, Anne‐Sophie Rigaud, Susanna Schraen‐Maschke, Audrey Gabelle
Published 2022Artigo
Search Tools:
Related Subjects
Alzheimer's disease
Dementia
Disease
Gastroenterology
Internal medicine
Medicine
Amyloid (mycology)
Apolipoprotein E
Biochemistry
Biomarker
Cerebrospinal fluid
Chemistry
Cognitive decline
Cognitive impairment
Cohort
Cohort study
Confidence interval
Endocrinology
Hazard ratio
Magnetic resonance imaging
Oncology
Pathology
Psychology
Quartile
Radiology